|
||||||||||||
| Users Online: 317 |
 
   |
|||||||||||
|
|||||||||||||||||
|
|
|||||||||||||||||
|
 Reader
Comments
Year : 2021 | Volume: 11 | Issue Number: 1 REVIEW ARTICLEFiribastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: A review of clinical trials Alomar Sara Abdulrahman, Alghabban Sarah Ali, Alharbi Hadeel Abdulaziz, Almoqati Mehad Fahad, Alduraibi Yazid, Abu-Zaid Ahmed
|
||||||||||||||
|
||||||
